These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 15574764

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
    Zoumpourlis V, Papassava P, Linardopoulos S, Gillespie D, Balmain A, Pintzas A.
    Oncogene; 2000 Aug 17; 19(35):4011-21. PubMed ID: 10962557
    [Abstract] [Full Text] [Related]

  • 3. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA, Merlino G.
    Oncogene; 2002 Feb 07; 21(7):1000-8. PubMed ID: 11850817
    [Abstract] [Full Text] [Related]

  • 4. Injury-specific expression of activating transcription factor-3 in retinal ganglion cells and its colocalized expression with phosphorylated c-Jun.
    Takeda M, Kato H, Takamiya A, Yoshida A, Kiyama H.
    Invest Ophthalmol Vis Sci; 2000 Aug 07; 41(9):2412-21. PubMed ID: 10937548
    [Abstract] [Full Text] [Related]

  • 5. The transcription factor ATF3 is upregulated during chondrocyte differentiation and represses cyclin D1 and A gene transcription.
    James CG, Woods A, Underhill TM, Beier F.
    BMC Mol Biol; 2006 Sep 19; 7():30. PubMed ID: 16984628
    [Abstract] [Full Text] [Related]

  • 6. Activation of the rat cyclin A promoter by ATF2 and Jun family members and its suppression by ATF4.
    Shimizu M, Nomura Y, Suzuki H, Ichikawa E, Takeuchi A, Suzuki M, Nakamura T, Nakajima T, Oda K.
    Exp Cell Res; 1998 Feb 25; 239(1):93-103. PubMed ID: 9511728
    [Abstract] [Full Text] [Related]

  • 7. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
    Kumar R, Alam S, Chaudhari BP, Dwivedi PD, Jain SK, Ansari KM, Das M.
    Carcinogenesis; 2013 Mar 25; 34(3):647-57. PubMed ID: 23172667
    [Abstract] [Full Text] [Related]

  • 8. Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes.
    Rutberg SE, Adams TL, Glick A, Bonovich MT, Vinson C, Yuspa SH.
    Cancer Res; 2000 Nov 15; 60(22):6332-8. PubMed ID: 11103794
    [Abstract] [Full Text] [Related]

  • 9. The transcription factor ATF-2 inhibits extracellular signal regulated kinase expression and proliferation of human cancer cells.
    Crowe DL, Shemirani B.
    Anticancer Res; 2000 Nov 15; 20(5A):2945-9. PubMed ID: 11062705
    [Abstract] [Full Text] [Related]

  • 10. Transactivation of the ApoCIII promoter by ATF-2 and repression by members of the Jun family.
    Hadzopoulou-Cladaras M, Lavrentiadou SN, Zannis VI, Kardassis D.
    Biochemistry; 1998 Oct 06; 37(40):14078-87. PubMed ID: 9760243
    [Abstract] [Full Text] [Related]

  • 11. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model.
    Cooper SJ, MacGowan J, Ranger-Moore J, Young MR, Colburn NH, Bowden GT.
    Mol Cancer Res; 2003 Sep 06; 1(11):848-54. PubMed ID: 14517347
    [Abstract] [Full Text] [Related]

  • 12. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
    Zhang SY, Liu SC, Goodrow T, Morris R, Klein-Szanto AJ.
    Mol Carcinog; 1997 Mar 06; 18(3):142-52. PubMed ID: 9115584
    [Abstract] [Full Text] [Related]

  • 13. A dominant negative c-jun specifically blocks okadaic acid-induced skin tumor promotion.
    Thompson EJ, MacGowan J, Young MR, Colburn N, Bowden GT.
    Cancer Res; 2002 Jun 01; 62(11):3044-7. PubMed ID: 12036911
    [Abstract] [Full Text] [Related]

  • 14. Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.
    van Dam H, Castellazzi M.
    Oncogene; 2001 Apr 30; 20(19):2453-64. PubMed ID: 11402340
    [Abstract] [Full Text] [Related]

  • 15. Role of basic region leucine zipper transcription factors cyclic AMP response element binding protein (CREB), CREB2, activating transcription factor 2 and CAAT/enhancer binding protein alpha in cyclic AMP response element-mediated transcription.
    Thiel G, Al Sarraj J, Vinson C, Stefano L, Bach K.
    J Neurochem; 2005 Jan 30; 92(2):321-36. PubMed ID: 15663480
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Activating transcription factor 2 targets c-Fos, but not c-Jun, in growth plate chondrocytes.
    Li X, LuValle P.
    J Cell Biochem; 2011 Jan 30; 112(1):211-6. PubMed ID: 21069729
    [Abstract] [Full Text] [Related]

  • 18. Adrenomedullin promotes cell cycle transit and up-regulates cyclin D1 protein level in human glioblastoma cells through the activation of c-Jun/JNK/AP-1 signal transduction pathway.
    Ouafik L, Berenguer-Daize C, Berthois Y.
    Cell Signal; 2009 Apr 30; 21(4):597-608. PubMed ID: 19166930
    [Abstract] [Full Text] [Related]

  • 19. Activation of c-Jun and ATF-2 in primate motor cranial nerve nuclei is not associated with apoptosis following axotomy.
    Colby GP, Coon AL, Connolly ES, Ambron RT.
    Exp Neurol; 2005 Jul 30; 194(1):57-65. PubMed ID: 15899243
    [Abstract] [Full Text] [Related]

  • 20. JunB negatively regulates AP-1 activity and cell proliferation of malignant mouse keratinocytes.
    Finch S, Joseloff E, Bowden T.
    J Cancer Res Clin Oncol; 2002 Jan 30; 128(1):3-10. PubMed ID: 11862466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.